Home » Cardiovascular » PRECISION Trial: Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

PRECISION Trial: Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis

This visual abstract represents the important findings of the PRECISION trial. The trial compares the COX-2 selective NSAID celecoxib with traditionally used NSAIDs such as naproxen and ibuprofen. It establishes non inferiority in terms of cardiovascular events and superiority in terms of GI and renal safety. As of March 2017, no guidelines have been published that reflect the results of this trial.

Source: NEJM

Subscribe via email